Tori Marsh - June 14, 2018
Brand drugs are expensive — this we already know, and prices seem to only be increasing. Of the 100 most-prescribed brand-name medications, those for diabetes, rheumatoid arthritis, and Crohn’s disease tend to be the most expensive. All of the drugs on this list are brand-only medications, meaning that there are no affordable generic alternatives available.
Additionally, it can be difficult for people to receive adequate insurance coverage for many of these drugs as they may be placed in more expensive, higher-tier formularies or have some other coverage restrictions. See More
Dr. Sharon Orrange - October 07, 2015
HIV Pre-exposure Prophylaxis, or PrEP, is an important new HIV prevention option for folks who do not have HIV infection, but are at significant risk for acquiring it. Did you know that you can take one pill a day to prevent acquiring HIV?
The medication approved by the FDA for HIV PrEP is emtricitabine/tenofovir (Truvada).
Dr. Sharon Orrange - June 03, 2015
In the last decade, billions of dollars have been spent to develop hundreds of new prescription drugs. While some drugs may not necessarily save lives (a prescription for longer eyelashes, anyone?), a handful of drugs have literally stopped major diseases in their tracks. Imagine that just ten years ago a patient might not be alive months or years after a diagnosis, whereas today a simple pill can cure or prevent a deadly disease. See More
Roni Shye - March 24, 2015
When you pick up your medications at the pharmacy you may notice that they are typically dispensed in amber colored vials or plastic containers. You may or may not be aware that these amber colored vials are not the original bottle the manufacturer dispensed the medication in.
For the majority of medications, transferring them from the manufacturer’s original bottle to the pharmacy’s amber vials is not a big deal, and lets the pharmacy purchase in bulk (which is more cost-effective)—unless you are taking certain medications. See More
Dr. Sharon Orrange - July 23, 2012
Update 5/29/2014: On May 14, 2014, the US Public Health Service released the first HIV pre-exposure prophylaxis (PrEP) guidelines, developed by the CDC and other agencies. The guidelines mention the first study referenced below, which showed that Truvada reduced risk overall by 44% in the population studied. However, in even better news, among men with detectable levels of medicine in their blood, the risk was actually reduced by as much as 92%. See More